Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Senseonics Holdings, Inc. Common Stock(SENS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for SENS
10/02/2026: SENS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Senseonics Holdings, Inc. is a medical technology company known for its Eversense line of long-term, implantable continuous glucose monitoring systems. Its primary strength lies in offering a unique, less-frequent site-change experience compared to traditional wearable sensors. The investment story revolves around gaining market share in a multi-billion dollar diabetes care sector, though the company faces significant competition from large, entrenched players. Key risks include heavy reliance on commercial partners, high cash burn, and intense industry competition that may hinder profitability. This stock may suit speculative growth investors, but market participants should monitor clinical adoption trends and the company's progress toward achieving a self-sustaining financial profile.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company targets a high-growth market but faces significant challenges in achieving scale and profitability. |
| Momentum investor | Weak fit | Momentum fit is conditional on a clear, sustained upturn in price and adoption, which has historically been erratic. |
| Value investor | Weak fit | Senseonics lacks the stable cash flows and earnings required for traditional value investing. |
| Dividend investor | Weak fit | The company does not pay dividends and prioritizes capital preservation for R&D. |
| Low-risk investor | Weak fit | The stock exhibits high volatility and operational risk, making it unsuitable for risk-averse portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is highly sensitive to news, clinical trial results, and commercial partnership updates. |
| Valuation risk | High | Valuation is often based on long-term potential rather than current financial performance. |
| Competition risk (CGM incumbents) | High | Dominant competitors have vast resources to squeeze smaller players via pricing and technology cycles. |
| Business quality | Medium | The company has a unique product, but it lacks the scale of diversified medical device franchises. |
| Dividend income | Low / none | No income is returned to shareholders; this is purely a capital appreciation play. |
| Execution risk | High | Successful commercialization depends on both product performance and partner execution. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -71.22% | Avg. Invested days 16 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 526.63M USD | Price to earnings Ratio - | 1Y Target Price 14.2 |
Price to earnings Ratio - | 1Y Target Price 14.2 | ||
Volume (30-day avg) 701.6K shares | Beta 1.08 | 52 Weeks Range 4.79 - 11.58 | Updated Date 10/02/2026 |
52 Weeks Range 4.79 - 11.58 | Updated Date 10/02/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.24 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Eversense CGM Revenue | Revenue from the sale of implantable glucose sensors and the associated smart transmitters. | Revenue depends on how many patients and doctors choose the long-term implantable Eversense system over standard wearables. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 21.01 | Enterprise Value 446.60M | Price to Sales(TTM) 10.85 |
Enterprise Value 446.60M | Price to Sales(TTM) 10.85 | ||
Enterprise Value to Revenue 9.2 | Enterprise Value to EBITDA 1.76 | Shares Outstanding 52.87M | Shares Floating 43.60M |
Shares Outstanding 52.87M | Shares Floating 43.60M | ||
Percent Insiders 9.86 | Percent Institutions 39.64 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Senseonics Holdings, Inc. Common Stock
Exchange NASDAQ | Headquarters Germantown, MD, United States | ||
IPO Launch date 2016-03-17 | President, CEO & Director Dr. Timothy T. Goodnow Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 130 | Website https://www.senseonics.com |
Full time employees 130 | Website https://www.senseonics.com | ||
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.